Indication

Superficial basal cell carcinoma

Superficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis. Read more about Superficial basal cell carcinoma

28 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Superficial basal cell carcinoma therapies.

Showing 19–27 of 28 drugs

FLUOROURACIL

SUPERFICIAL BASAL CELL CARCINOMA·+1
SPEAR PHARM/MAY

FLUOROURACIL

SUPERFICIAL BASAL CELL CARCINOMA·+1
LIBERTAS PHARMA

FLUOROURACIL

ACTINIC KERATOSES AGENTS·SUPERFICIAL BASAL CELL CARCINOMA·+1
NORTHSTAR RX LL

FLUOROURACIL

ACTINIC KERATOSES AGENTS·SUPERFICIAL BASAL CELL CARCINOMA·+1
ENCUBE ETHICALS

FLUOROURACIL

ACTINIC KERATOSES AGENTS·SUPERFICIAL BASAL CELL CARCINOMA·+1
DR.REDDY'S LAB

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES·EXTERNAL CONDYLOMATA ACUMINATA·+2
BRYANT RANCH PR

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES·EXTERNAL CONDYLOMATA ACUMINATA·+2
Padagis US

FLUOROURACIL

ACTINIC KERATOSES AGENTS·SUPERFICIAL BASAL CELL CARCINOMA·+1
TARO/SUN PHARMA
Filter & compare in the drug finder →Opens the drug finder with Superficial basal cell carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Superficial basal cell carcinoma.

Superficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis.

It predominantly affects adults with fair skin types and extensive cumulative or intermittent ultraviolet radiation exposure, frequently developing on the trunk, shoulders, and extremities.

Clinically, lesions present as slowly enlarging, well-demarcated, erythematous, scaly macules or thin plaques that often display subtle thread-like pearly borders, focal crusting, or fine telangiectasias, frequently mimicking inflammatory dermatoses such as eczema or psoriasis.

Histopathologically, it is characterized by horizontal, multifocal buds and lobules of atypical basaloid cells extending from the basal epidermis into the papillary dermis without deeper dermal invasion.

Personalize your experience

Follow Superficial basal cell carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it